¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"common intermediate principle"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • consistency principle
    Àϰü¼º¿ø¸®
  • principle
    ¿ø¸®, ¿øÄ¢
  • pulse echo principle
    ÆÞ½º¿¡ÄÚ¿ø¸®
  • reality principle
    Çö½Ç¿øÄ¢
  • repetition compulsion principle
    ¹Ýº¹°­¹Ú¿øÄ¢
  • spherical gliding principle
    °ø¹Ì²ô·³¿ø¸®, ±¸ÇüȰ°­¿ø¸®
  • intermediate
    1. Áß°£- 2. Áß°£¹°
  • intermediate body
    Áß°£¼Òü
  • intermediate care facility
    Áß°£Ä¡·á½Ã¼³
  • intermediate cell mass
    Áß°£¼¼Æ÷µ¢ÀÌ, Áß°£¼¼Æ÷±«
  • intermediate coupling
    Áß°£°áÇÕ
  • intermediate density lipoprotein
    Á߹еµÁöÁú´Ü¹éÁú
  • intermediate field magnetic resonance scanner
    ÁßµîÀÚÀåÀÚ±â°ø¸í½ºÄ³³Ê
  • intermediate ganglion
    Áß°£½Å°æÀý
  • intermediate host
    Áß°£¼÷ÁÖ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 7 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • intermediate host
    Áß°£¼÷ÁÖ
  • intermediate
    Áß°£-, Áß°£¹°
  • principle
    ¿ø¸®, ¿øÄ¢
  • reality principle
    Çö½Ç¿øÄ¢
  • common carotid artery
    ¿Â¸ñµ¿¸Æ
  • common
    °øµ¿-, º¸Åë-, ¿Â-
  • common bile duct
    ¿Â¾µ°³°ü, ÃÑ´ã°ü
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • principle
    ¿ø¸®, ¿øÄ¢
  • pulse echo principle
    ÆÞ½º¿¡ÄÚ¿ø¸®
  • reality principle
    Çö½Ç¿øÄ¢
  • repetition compulsion principle
    ¹Ýº¹°­¹Ú¿øÄ¢
  • spherical gliding principle
    °ø¹Ì²ô·³¿ø¸®, ±¸ÇüȰ°­¿ø¸®
  • intermediate body
    Áß°£¼Òü
  • intermediate coupling
    Áß°£°áÇÕ
  • intermediate care facility
    Áß°£Ä¡·á½Ã¼³
  • intermediate ganglion
    Áß°£½Å°æÀý
  • intermediate host
    Áß°£¼÷ÁÖ
  • intermediate hybrid
    Áß°£ÀâÁ¾
  • intermediate
    Áß°£-, Áß°£¹°
  • intermediate inheritance
    Áß°£À¯Àü
  • intermediate mesoderm
    Áß°£Á߹迱
  • intermediate nephron
    Áß°£ÄáÆÏ´ÜÀ§
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Final common path
    ÃÖÁ¾(õÌðû)°øÅë(Íì÷×)Åë·Î(÷×ÖØ)
  • proximal common pathway
    ±ÙÀ§°øÅë°æ·Î.
  • IDL = intermediate density lipoprotein
    Á߹еµÁö´Ü¹é(ñéÚËÓøò·Ó±ÛÜ)
  • Intermediate density lipoprotein =IDL
    Á߹еµÁö´Ü¹é(ñéÚËÓøò·Ó±ÛÜ)
  • Intermediate filaments
    Áß°£¼¼»ç(ñéÊàá¬Þê)
  • Intermediate part(commissura) of bulb
    Áú¾î±Í¸Á¿ïÁß°£ºÎºÐ
  • gigantocellular intermediate reticular nucleus
    °Å´ë¼¼Æ÷Áß°£±×¹°ÇÙ
  • inferior pontine intermediate reticular nuleus
    ¾Æ·¡´Ù¸®³úÁß°£±×¹°ÇÙ
  • pituitary intermediate lobe
    ³úÇϼöüÁß°£¿±, ³úÇϼöüÁß¿±(¡­ñéç¨).
  • posterior intermediate sulcus
    µÚÁß°£°í¶û
  • reactive intermediate
    ¹ÝÀÀ¼º Áß°£¹°Áú.
  • Adansonian principle
    ¾Æ´Ü¼Õ¿ø¸®
  • Fick principle
    ÇÈ¿ø¸®, ¿ëÁúÈ®»ê¹ýÄ¢.
  • Ficks principle
    ÇÈÀÇ ¿øÄ¢(ê«öÎ)
  • Frequency principle
    µµ¼ö¿øÄ¢(Óøâ¦ê«öÎ)
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • all-or-none law =all-or-none principle
    ´Ù³Ä ¾Æ´Ï³ÄÀÇ ¹ýÄ¢, ½Ç¹«À²
  • epigenetic principle
    °³Ã¼½Å»ý¿øÄ¢
  • follicle stimulating principle
    ³­Æ÷ÀڱؼººÐ(Õ°øàí©Ð½à÷ÝÂ).
  • glycotropic principle
    ´çģȭ¼º ¼ººÐ(ÓØöÑûúàõà÷ÝÂ).
  • isohydric principle
    µî¼ö¼Ò(Ôõâ©áÈ)À̿³óµµÀÇ ¿øÄ¢(ê«öÎ).
  • luteinizing principle
    Ȳüȭ¼ººÐ(üÜô÷ûù àõÝÂ).
  • natriuretic factor =n. principle
    ³ªÆ®·ý¹è¼³ÃËÁøÀÎÀÚ.
  • neutral principle
    Áß¼º¼ººÐ.
  • nirvana principle
  • organic principle
    À¯±â¼ººÐ(¡­à÷ÝÂ).
  • pleasure principle
    Äè¶ô¿øÄ¢, ÃæÁ·¿ø¸®(õöðë ê«ìµ).
  • priming principle
    ÃæÁø¿ø¸®, »çÀü¿¹ºñÁ¤ ÁÖ¹ý.
  • principle
    ¿ø¸®(ê«×â)
  • principle of convergence
    ÆøÁÖ¿øÄ¢(ÜßñÍ ê«öÎ).
  • principle of divergence
    ¹ß»ê¿øÄ¢(ۡߤ ê«öÎ).
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Common synovial sheath of flexors of fingers
    (¼Õ°¡¶ô)±ÁÈû±Ù¿ÂÈûÁÙÁý
    [¿¾ ¿ë¾î] (¼ö)Áö±¼±ÙÃѰÇÃÊ
  • Common hepatic duct
    ¿Â°£°ü
    [¿¾ ¿ë¾î] ÃѰ£°ü
  • Common hepatic artery
    ¿Â°£µ¿¸Æ
    [¿¾ ¿ë¾î] ÃѰ£µ¿¸Æ
  • Common cardinal vein
    ¿Â±âº»Á¤¸Æ
    [¿¾ ¿ë¾î] ÃÑÁÖÁ¤¸Æ
  • Common dorsal mesentery
    ¿ÂµîÂÊâÀÚ°£¸·
    [¿¾ ¿ë¾î] ÃѹèÃøÀå°£¸·
  • Common carotid artery
    ¿Â¸ñµ¿¸Æ
    [¿¾ ¿ë¾î] ÃѰ浿¸Æ(°£)
  • Common carotid artery (partial)
    ¿Â¸ñµ¿¸Æ(ºÎºÐ)
    [¿¾ ¿ë¾î] ÃѰ浿¸Æ
  • Common carotid plexus
    ¿Â¸ñ½Å°æ¾ó±â
    [¿¾ ¿ë¾î] ÃѰ浿¸Æ½Å°æÃÑ
  • Common basal vein
    ¿Â¹Ù´ÚÁ¤¸Æ
    [¿¾ ¿ë¾î] ÃÑÆóÀúÁ¤¸Æ
  • Common plantar digital arteries
    ¿Â¹Ù´ÚÂʹ߰¡¶ôµ¿¸Æ
    [¿¾ ¿ë¾î] ÃÑ̫̿Áöµ¿¸Æ
  • Common plantar digital nerves
    ¿Â¹Ù´ÚÂʹ߰¡¶ô½Å°æ
    [¿¾ ¿ë¾î] ÃÑ̫̿Áö½Å°æ
  • Common palmar digital arteries
    ¿Â¹Ù´ÚÂʼհ¡¶ôµ¿¸Æ
    [¿¾ ¿ë¾î] ÃÑÀåÃøÁöµ¿¸Æ
  • Common palmar digital nerves
    ¿Â¹Ù´ÚÂʼհ¡¶ô½Å°æ
    [¿¾ ¿ë¾î] ÃÑÀåÃøÁö½Å°æ
  • Common membranous crus
    ¿Â¹Ý°í¸®°ü´Ù¸®
    [¿¾ ¿ë¾î] ÃѰ¢
  • Common interosseous artery
    ¿Â»À»çÀ̵¿¸Æ
    [¿¾ ¿ë¾î] ÃѰñ°£µ¿¸Æ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 4 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • common vehicle
    °øÅë¸Å°³Ã¼
  • first intermediate host
    Á¦ÀÏÁß°£¼÷ÁÖ
  • intermediate host
    Áß°£¼÷ÁÖ
  • second intermediate host
    Á¦ÀÌÁß°£¼÷ÁÖ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • common intermediate principle
    °øÅë Áß°£Ã¼¿ø¸®(Íì÷×ñéÊàô÷ê«×â)
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 11 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • covalent intermediate
    °øÀ¯°áÇÕ Áß°£»ê¹°(ÍìêóÌ¿ùêñéÊàß§Úª)
  • enzyme-substrate intermediate
    È¿¼Ò-±âÁú Áß°£Ã¼ (ý£áÈÐñòõñéÊàô÷)
  • intermediate
    Áß°£¹°(ñéÊàÚª)
  • lipid intermediate
    ÁöÁúÁß°£´ë»ç¹°(ò·òõñéÊàÓÛÞóÚª)
  • tetrahedral intermediate
    »ç¸éüÇü Áß°£´ë»ç¹° (ÞÌØüô÷û¡ñéÊàÓÛÞóÚª)
  • anthropic principle
    À¯Àοø¸®(ëºìÑê«×â)
  • condensation principle
    ÃàÇÕ¿ø¸®(õêùêê«×â)
  • condensing principle
    ÃàÇÕ¿ø¸®(õêùêê«×â)
  • neighbor-exclusion principle
    ±ÙÁ¢¹èÁ¦ ¿ø¸®(ÐÎïÈÛÉð¶ê«×â)
  • principle of evolutionary continuity
    ÁøÈ­¿¬¼Ó¿ø¸®(òäûùææáÙê«×â)
  • transforming principle
    ÇüÁúÀüȯ¼Ò( û¡òõï®üµáÈ)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 14 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • intermediate
    Áß°£ÀÇ, Áß°£¹°
  • intermediate field MR scanner
    ÁßµîÀÚÀå ÀÚ±â°ø¸í½ºÄ³³Ê
  • intermediate nerve
    Áß°£½Å°æ
  • all-or-none principle
    ´Ù³Ä¾Æ´Ï³ÄÀÇ ¿ø¸®, ½Ç¹«À²
  • Huygen's principle
    È£À̰տø¸®
  • principle
    ¼ººÐ, ¿ø¸®
  • pulse echo principle
    ÆÞ½º¿¡ÄÚ¿ø¸®
  • CGI(common gateway interface)
    CGI
  • common atrioventricular canal
    °øÅë¹æ½Ç°ü
  • common bile duct
    ÃÑ´ã°ü
  • common carotid artery
    ÃѸñµ¿¸Æ, ÃѰ浿¸Æ
  • common cold
    °¨±â
  • common hepatic artery
    ÃѰ£µ¿¸Æ
  • common iliac artery
    ÃÑÀå°ñµ¿¸Æ
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
IDL Index to Dental Literature; interface definition language; intermediate density lipoprotein; interme...
IF idiopathic fibroplasia; idiopathic flushing; immersion foot; immunofluorescence; indirect fluorescen...
IM idiopathic myelofibrosis; immunosuppressive method; implementation monitoring; Index Medicus; indome...
SAID specific adaptation to imposed demand [principle]
TIP thermal inactivation point; Toxicology Information Program; translation-inhibiting protein; tumor-in...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
PCA Principle component analysis
ERGIC ER Golgi intermediate compartment
I Intermediate
Int Intermediate
ICFs Intermediate Care Facilities
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • active principle
    À¯È¿¼ººÐ
    ¾à¹°ÀÇ È¿°ú¸¦ ºÎ¿©ÇÏ´Â ¾à¹° ÁßÀÇ ¼ººÐ
  • all-or-none principle
    ´Ù³Ä ¾Æ´Ï³ÄÀÇ ¿ø¸®, ½Ç¹«À²
  • antianemia principle
    Ç׺óÇ÷ ÀÎÀÚ
    ¾Ç¼º ºóÇ÷¿¡ »ç¿ëÇÏ¿© Á¶Ç÷ ÃËÁø È¿°ú¸¦ ³ªÅ¸³»´Â °£Àå³»ÀÇ ¼ººÐ ¹× ±âŸ Á¶Á÷³» ¼ººÐ.
  • corticotropin-like intermediate lobe peptide

    corticotropin-releasing factor (ºÎ½Å ÇÇÁú È£¸£¸ó À¯¸® ¿ä¼Ò, ºÎ½Å ÇÇÁú È£¸£¸ó À¯¸® ÀÎÀÚ

  • Huygen's principle
    È£ÀÌ°Õ ¿ø¸®
  • intermediate
    Áß°£ÀÇ, Áß°£¹°, Áß°£Ã¼, Áß°£¹°Áú
    1. ¾ç±Ø´ÜÀÇ ½Ö¹æ¿¡ ÀϺΠÀ¯»çÇÑ. 2. ¹ÝÀÀÀÇ ÃÖÁ¾ »ê¹° Çü¼º¿¡ ÇʼöÀûÀÎ È­ÇÐ ¹ÝÀÀÀÇ °úÁ¤ Áß¿¡ ¸¸µé¾îÁö´Â ¹°Áú.
  • intermediate body of Flemming
    Ç÷¹¹Ö Áß°£Ã¼
    À¯»ç ºÐ¿­ÀÇ ÃÖÁ¾ ´Ü°è¿¡ À־ µÎ °³ÀÇ ³¶ ¼¼Æ÷¸¦ ¿¬°á½ÃŰ´Â È£»ê¼º ¹°ÁúÀÇ ÀÛÀº Áö¸§ ´Ù¸®.
  • intermediate cell
    Áß°£ ¼¼Æ÷
    ÁßÃþ ÆíÆò »óÇÇ Á¶Á÷ÀÇ Áß°£Ãþ, ÁÖ·Î °ú¸³ ¼¼Æ÷ÃþÀ» Â÷ÁöÇÏ´Â ¼¼Æ÷·Î¼­ ¼¼ Æ÷Áø¿¡¼­´Â Ç¥Ãþ ¼¼Æ÷º¸´Ù ¾à°£ ÀÛ¾Æ 30-50 ¸¶ÀÌÅ©·Î¹ÌÅÍÀÇ ´Ù°¢ÇüÀ̳ª À¯¿øÇüÀÇ ¿¯Àº ¼¼Æ÷ÁúÀ» Áö´Ñ ÆíÆòÇÑ ¼¼Æ÷. ÇÙÀº ¼¼Æ÷ÀÇ Á߽ɿ¡ ÀÖÀ¸¸ç, Ç¥Ãþ ¼¼Æ÷º¸´Ù´Â ¾à°£ Å©°í, ¼ÒÆ÷»óÀÇ ÇÙ³» ±¸Á¶¸¦ °üÂûÇÒ ¼ö ÀÖ´Ù.
  • intermediate field MR scanner
    Áßµî ÀÚÀå Àڱ⠰ø¸í ½ºÄ³³Ê
  • intermediate junction
    ºÎÂø ¶ì
    µ¿ÀǾî=zonula adherens. Æó¼â ¶ìó·³ ¼¼Æ÷¸¦ ¿ÏÀüÈ÷ µÑ·¯ ½Î¸ç Æó¼â ¶ìÀÇ ¹Ù·Î ¾Æ·¡¿¡ À§Ä¡ÇÑ´Ù. ¼¼Æ÷ »çÀÌ¿¡ ÆøÀÌ 20-25§¬ÀÎ ÀÏÁ¤ÇÑ °ø°£ÀÌ Á¸ÀçÇϴµ¥ ÀÌ °ø°£Àº ÀüÀÚ ¹Ðµµ°¡ ³·¾Æ °ÅÀÇ Åõ¸íÇÏ°Ô º¸À̸ç ÀÌ ¾È¿¡ µé¾î ÀÖ´Â ¹°ÁúÀÌ µÎ °³ÀÇ ÇüÁú¸· ºÎÂø¿¡ Áß¿äÇÑ ¿ªÇÒÀ» ÇÒ °ÍÀ¸·Î ¹Ï¾îÁö³ª ¾ÆÁ÷ ¾î¶² ¹°ÁúÀÎÁö´Â ¹àÇôÁ® ÀÖÁö ¾Ê´Ù.
  • intermediate movement
    Áß°£ ÇÏ¾Ç ¿îµ¿
    ÇϾǰñÀÌ ¿îµ¿ÇÒ ¼ö ÀÖ´Â ÃÖ´ëÀÇ ¿îµ¿ ¹üÀ§ ³»¿¡¼­ ÀϾ´Â ¸ðµç ¿îµ¿.
  • intermediate syndrome
    Áß°£Çü ÁõÈıº
  • intermediate zone
    Áß°£´ë, Áß¾ÓºÎ, °üÀý ¿øÆÇ Áß°£ºÎ
  • isohydric principle
    µî ¼ö¼Ò ¿ø¸®
  • lateral intermediate substance
    °¡ÂÊ Áß°£ ȸ»öÁú
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
common intermediate <biochemistry, chemistry> A molecule that is shared by two chemical reactions as a product of the first and a reactant in the second.
(09 Oct 1997)
active principle A constituent of a drug, usually an alkaloid or glycoside, upon the presence of which the characteristic therapeutic action of the substance largely depends.
(05 Mar 2000)
antianaemic principle The material in liver (and certain other tissues) that stimulates haemopoiesis in pernicious anaemia; for practical purposes, the antianaemic effect of extracts from such tissues is approximately equivalent to the content of vitamin B12.
(05 Mar 2000)
azygos vein principle A principle based on the observation that animals can survive prolonged vena caval occlusion without sequelae: if blood from the azygos vein alone is permitted to enter the heart, patients are perfused during cardiac and pulmonary bypass at flows much less than the normal resting cardiac output.
Synonym: low flow principle.
(05 Mar 2000)
Bernoulli's principle <physics> When friction is negligible, the velocity of flow of a gas or fluid through a tube is inversely related to its pressure against the side of the tube; i.e., velocity is greatest and pressure lowest at a point of constriction.
Synonym: Bernoulli's principle, Bernoulli's theorem.
(05 Mar 2000)
pain-pleasure principle A psychoanalytic concept that, in a human's psychic functioning, he/she tends to seek pleasure and avoid pain; a term borrowed by experimental psychology to denote the same tendency of an animal in a learning situation.
Synonym: pleasure principle.
(05 Mar 2000)
reality principle The concept that the pleasure principle in personality development is modified by the demands of external reality; the principle or force that compels the growing child to adapt to the demands of external reality.
(05 Mar 2000)
Pauli's exclusion principle The theory limiting the number of electrons in the orbit or shell of an atom; that it is not possible for any two electrons to have all four quantum numbers identical.
(05 Mar 2000)
repetition-compulsion principle In psychoanalysis, the impulse to redramatise or reenact earlier emotional experiences or situations.
Synonym: principle of inertia.
(05 Mar 2000)
melanophore-expanding principle A polypeptide hormone secreted by the intermediate lobe of the hypophysis in humans (in neurohypophysis in certain other species) which causes dispersion of melanin by melanophores, resulting in darkening of the skin, presumably by promoting melanin synthesis; this effect is readily demonstated in some lower vertebrates, such as frogs and fish; alpha-melanotropin is an N-acetylated peptide with 13 amino acids; beta-melanotropin has 22 amino acids.
Synonym: intermedin, melanocyte-stimulating hormone, melanophore-expanding principle.
(05 Mar 2000)
Mitrofanoff principle Use of an isolated appendix on a vascularised pedicle as a catheterizable route of access to the bladder from the skin.
Synonym: Mitrofanoff principle.
Origin: eppendico-+ L. Vesica, bladder, + G. Stoma, mouth
(05 Mar 2000)
closure principle In psychology, the principle that when one views fragmentary stimuli forming a nearly complete figure (e.g., an incomplete rectangle) one tends to ignore the missing parts and perceive the figure as whole.
See: gestalt.
(05 Mar 2000)
pleasure-pain principle The psychoanalytic concept that man instinctively seeks to avoid pain and discomfort and strives for gratification and pleasure.
(12 Dec 1998)
pleasure principle A psychoanalytic concept that, in a human's psychic functioning, he/she tends to seek pleasure and avoid pain; a term borrowed by experimental psychology to denote the same tendency of an animal in a learning situation.
Synonym: pleasure principle.
(05 Mar 2000)
consistency principle In psychology, the desire of the human being to be consistent, especially in his attitudes and beliefs; theories of attitude formation and change based on the consistency principle include balance theory, which suggests that the individual seeks to avoid incongruity in his various attitudes.
See: cognitive dissonance theory.
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • intermediate
    Áß°£¿¡ ÀÖ´Â
  • intermediate
    Áß°£ÀÇ;°³ÀçÇÏ´Â;Áß°£¿¡ ÀϾ´Â;Áß°£¹°;ÁßÀç(Áß°³)ÀÚ Áß°£½ÃÇè;ÁßÇüÂ÷;»çÀÌ¿¡ µé¾î°¡´Ù;ÁßÀçÇÏ´Ù;Áß°³ÇÏ´Ù
  • intermediate frequency
    Áß°£Á֯ļö
  • intermediate host
    Áß°£¼÷ÁÖ(±â»ýÃæÀÇ À¯»ý±âÀÇ ¼÷ÁÖ)
  • intermediate range ballistic missile
    Á߰Ÿ® ŸµµÅº
  • intermediate school
    ÁßÇб³;(¹Ì)±¹¹ÎÇб³4-6Çг⠰úÁ¤ÀÇ Çб³;(¿µ)±¹¹ÎÇб³ »ó±Þ°ú ÁßÇб³ÀÇ Áß°£Çб³(12-14¼¼ ÇлýÀ» ¼ö¿ë)
  • intermediate technology
    Áß°£ °øÇÐ(¼Ò±Ô¸ðÀûÀÌ°í °£´ÜÇÑ ¹æ¹ýÀ̳ª ±â¼úÀ» Çö´ëÀÇ Ã·´Ü ±â¼úÀ̳ª ±â°è¿¡ °áºÎ½ÃŲ °øÇÐ)
  • principle
    ¿ø¸®,ÁÖÀÇ
  • Archimedes principle
    ¾Æ¸£Å°¸Þµ¥½ºÀÇ ¿ø¸®
  • Pauli exclusion principle
    ÆÄ¿ï¸®ÀÇ ¹èŸ(±ÝÁ¦) ¿ø¸®
  • Peter Principle
    ÇÇÅÍÀÇ ¹ýÄ¢ 
  • bernoulli's principle
    º£¸£´©ÀÌÀÇ Á¤¸®
  • correspondence principle
    ´ëÀÀ¿ø¸®
  • currency coctrine (principle)
    ÅëÈ­ ÁÖÀÇ
  • first principle
    Á¦1¿ø¸®;±Ùº» °¡¼³
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á